Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats

Hoon Lee Jang, Kyung Sung Dong, Hyun Koo Soo, Bong Kyung Shin, Young Sook Hong, Chang Sung Son, Won Lee Joo, Sil Chang Yun, Soon Park Won

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This study was done to determine whether recombinant human erythropoietin (rhEPO) treatment could attenuate hyperoxia-induced lung injury, and if so, whether this protective effect is mediated by the down-modulation of inflammation in neonatal rats. Newborn Sprague Dawley rat pups were subjected to 14 days of hyperoxia (>95% oxygen) within 10 hr after birth. Treatment with rhEPO significantly attenuated the mortality and reduced body weight gain caused by hyperoxia. With rhEPO treatment, given 3 unit/gm intraperitoneally at 4th, 5th, and 6th postnatal day, hyperoxia-induced alterations in lung pathology such as decreased radial alveolar count, increased mean linear intercept, and fibrosis were significantly improved, and the inflammatory changes such as myeloperoxidase activity and tumor necrosis factor-alpha expression were also significantly attenuated. In summary, rhEPO treatment significantly attenuated hyperoxia-induced lung injury by down-modulating the inflammatory responses in neonatal rats.

Original languageEnglish
Pages (from-to)1042-1047
Number of pages6
JournalJournal of Korean Medical Science
Volume22
Issue number6
DOIs
Publication statusPublished - 2007 Dec 1

Fingerprint

Hyperoxia
Lung Injury
Erythropoietin
Inflammation
Peroxidase
Weight Gain
Sprague Dawley Rats
Fibrosis
Tumor Necrosis Factor-alpha
Body Weight
Parturition
Pathology
Oxygen
Lung
Mortality

Keywords

  • Animals, newborn
  • Bronchopulmonary dysplasia
  • Erythropoietin
  • Inflammation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats. / Jang, Hoon Lee; Dong, Kyung Sung; Soo, Hyun Koo; Shin, Bong Kyung; Hong, Young Sook; Son, Chang Sung; Joo, Won Lee; Yun, Sil Chang; Won, Soon Park.

In: Journal of Korean Medical Science, Vol. 22, No. 6, 01.12.2007, p. 1042-1047.

Research output: Contribution to journalArticle

Jang, Hoon Lee ; Dong, Kyung Sung ; Soo, Hyun Koo ; Shin, Bong Kyung ; Hong, Young Sook ; Son, Chang Sung ; Joo, Won Lee ; Yun, Sil Chang ; Won, Soon Park. / Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats. In: Journal of Korean Medical Science. 2007 ; Vol. 22, No. 6. pp. 1042-1047.
@article{4d33af82323f490b8bc7c4cc774c23cd,
title = "Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats",
abstract = "This study was done to determine whether recombinant human erythropoietin (rhEPO) treatment could attenuate hyperoxia-induced lung injury, and if so, whether this protective effect is mediated by the down-modulation of inflammation in neonatal rats. Newborn Sprague Dawley rat pups were subjected to 14 days of hyperoxia (>95{\%} oxygen) within 10 hr after birth. Treatment with rhEPO significantly attenuated the mortality and reduced body weight gain caused by hyperoxia. With rhEPO treatment, given 3 unit/gm intraperitoneally at 4th, 5th, and 6th postnatal day, hyperoxia-induced alterations in lung pathology such as decreased radial alveolar count, increased mean linear intercept, and fibrosis were significantly improved, and the inflammatory changes such as myeloperoxidase activity and tumor necrosis factor-alpha expression were also significantly attenuated. In summary, rhEPO treatment significantly attenuated hyperoxia-induced lung injury by down-modulating the inflammatory responses in neonatal rats.",
keywords = "Animals, newborn, Bronchopulmonary dysplasia, Erythropoietin, Inflammation",
author = "Jang, {Hoon Lee} and Dong, {Kyung Sung} and Soo, {Hyun Koo} and Shin, {Bong Kyung} and Hong, {Young Sook} and Son, {Chang Sung} and Joo, {Won Lee} and Yun, {Sil Chang} and Won, {Soon Park}",
year = "2007",
month = "12",
day = "1",
doi = "10.3346/jkms.2008.22.6.1042",
language = "English",
volume = "22",
pages = "1042--1047",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "6",

}

TY - JOUR

T1 - Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats

AU - Jang, Hoon Lee

AU - Dong, Kyung Sung

AU - Soo, Hyun Koo

AU - Shin, Bong Kyung

AU - Hong, Young Sook

AU - Son, Chang Sung

AU - Joo, Won Lee

AU - Yun, Sil Chang

AU - Won, Soon Park

PY - 2007/12/1

Y1 - 2007/12/1

N2 - This study was done to determine whether recombinant human erythropoietin (rhEPO) treatment could attenuate hyperoxia-induced lung injury, and if so, whether this protective effect is mediated by the down-modulation of inflammation in neonatal rats. Newborn Sprague Dawley rat pups were subjected to 14 days of hyperoxia (>95% oxygen) within 10 hr after birth. Treatment with rhEPO significantly attenuated the mortality and reduced body weight gain caused by hyperoxia. With rhEPO treatment, given 3 unit/gm intraperitoneally at 4th, 5th, and 6th postnatal day, hyperoxia-induced alterations in lung pathology such as decreased radial alveolar count, increased mean linear intercept, and fibrosis were significantly improved, and the inflammatory changes such as myeloperoxidase activity and tumor necrosis factor-alpha expression were also significantly attenuated. In summary, rhEPO treatment significantly attenuated hyperoxia-induced lung injury by down-modulating the inflammatory responses in neonatal rats.

AB - This study was done to determine whether recombinant human erythropoietin (rhEPO) treatment could attenuate hyperoxia-induced lung injury, and if so, whether this protective effect is mediated by the down-modulation of inflammation in neonatal rats. Newborn Sprague Dawley rat pups were subjected to 14 days of hyperoxia (>95% oxygen) within 10 hr after birth. Treatment with rhEPO significantly attenuated the mortality and reduced body weight gain caused by hyperoxia. With rhEPO treatment, given 3 unit/gm intraperitoneally at 4th, 5th, and 6th postnatal day, hyperoxia-induced alterations in lung pathology such as decreased radial alveolar count, increased mean linear intercept, and fibrosis were significantly improved, and the inflammatory changes such as myeloperoxidase activity and tumor necrosis factor-alpha expression were also significantly attenuated. In summary, rhEPO treatment significantly attenuated hyperoxia-induced lung injury by down-modulating the inflammatory responses in neonatal rats.

KW - Animals, newborn

KW - Bronchopulmonary dysplasia

KW - Erythropoietin

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=38349153043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349153043&partnerID=8YFLogxK

U2 - 10.3346/jkms.2008.22.6.1042

DO - 10.3346/jkms.2008.22.6.1042

M3 - Article

VL - 22

SP - 1042

EP - 1047

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 6

ER -